Ingersoll Rand Inc. IR
Ingersoll Rand's Q2 2026 earnings beat and raised full-year revenue guidance to 4.5%–6.5% signal a potential inflection after a difficult FY2025 in which gross margin compressed from 43.8% to 38.5% and net income fell 30.7%. However, at 33.6x trailing earnings — a 19.5% premium to the peer median of 28.1x — the stock already prices in a margin recovery that has yet to materialize, while total debt has climbed to $4.85B from $2.77B in FY2023 and insiders have been net sellers to the tune of $52.7M over 24 months.
With MACD histogram negative (-0.75) and smart money scores fading from 0.049 to 0.006 over two quarters, the risk/reward is balanced; the call waits for evidence that ITS segment margins are bottoming before turning more constructive.
What could go wrong
- Margin compression persists. FY2025 gross margin fell to 38.5% from 43.8% in FY2024; if ITS segment margin pressure continues, the premium valuation becomes harder to justify.
- Leverage from M&A. Total debt rose to $4.85B in FY2025 from $2.77B in FY2023, and continued acquisition activity (e.g., Lone Star Blower in August 2026) could further strain the balance sheet if synergies underperform.
- Insider selling. Over the trailing 24 months, insiders net sold 354,840 shares worth $52.7M with no cluster buying, suggesting limited management conviction at current levels.
- Valuation premium. P/E of 33.6x sits 19.5% above the peer median of 28.1x; any disappointment in order conversion or margin recovery could trigger a de-rating.
What would change my mind
Where this comes from: derived_metrics FY2025 vs FY2024 · derived_metrics FY2025 · peer_relative · fundamentals FY2025 and FY2023. Orin's read on IR; not advice.
Twelve months actual closes to 2026-09-23 · actual filings
50-day average 200-day average · volume below
On file
All IR filings| Form | Filed | What it says | Read |
|---|---|---|---|
| 13G/A | 14 Aug | — | on file |
| 13G/A | 12 Aug | — | on file |
| 13G/A | 6 Aug | — | on file |
| 10-Q | 31 Jul | Ingersoll Rand Inc. reported Q2 2026 revenues of $2,048.8 million, an increase of 8.5% year-over-year, driven by $77.5 million in higher organic revenues and $53.4 million from… | read |
| 8-K | 30 Jul | Ingersoll Rand reported Q2 2026 results with $2,049 million in revenue, up 9% year-over-year, driven by 4% organic growth. | read |
| 8-K | 16 Jun | Ingersoll Rand Inc. stockholders approved the 2026 Omnibus Incentive Plan on June 11, 2026, effective immediately. The plan's material terms were previously detailed in the April… | read |
| 13G | 15 May | — | on file |
| 13G/A | 15 May | — | on file |
Largest holders · 13F Q2 2026
Money flow| Filer | Position | Of fund |
|---|---|---|
| Capital World Investors | $2.3B | 0.3% of fund |
| Price T Rowe Associates /Md/ | $2.2B | 0.2% of fund |
| Capital Research Global Investors | $2.1B | 0.3% of fund |
| Vanguard Capital Management | $2.0B | 0.0% of fund |
| Vanguard Portfolio Management | $1.4B | 0.1% of fund |
| State Street | $1.3B | 0.0% of fund |
88 filers · quarter ended Q2 2026 · positions, not flows
Insiders, last 24 months: 243 Form 4 filings, net −$52.8M. Of the 50 on hand, 1 was an open-market purchase and 2 sales— the rest are grants, option exercises and tax withholding.
Ask Orin about IR
Orin answers questions about IR from its filings, transcripts and numbers — with the source behind every claim. Your own desk starts with 3 free days, card required.
Start 3 free days →Where it trades
| Metric | Now | Own median | Sector |
|---|---|---|---|
| P/E | 31.1× | 43.5× | 44.5× |
| EV/EBITDA | 17.0× | 19.7× | — |
| P/S | 3.76× | 4.55× | — |
| P/B | 2.9× | 3.1× | — |
Its P/E sits below all 5 of the last 5 years (−1.98σ from its own mean).
10.4%
free-cash-flow growth every year for 10 years, discounted at 10%, is what today’s price implies — starting from $1.2B of trailing free cash flow. It is an assumption the market is making, not a forecast Orin is making.
What Wall Street published
$91
$84 – $103 · +20% against today's price
- 8 buy or overweight
- 7 hold
- 0 underweight or sell
The analysts’ consensus and their own ratings, not Orin’s. A target is a twelve-month opinion published by the firm that wrote it.
Against the companies it is compared to
| Company | Market cap | P/E | EV/EBITDA | Gross | Net | ROE |
|---|---|---|---|---|---|---|
| IRIngersoll Rand Inc. | $30B | 31.1× | 17.0× | 37.9% | 12.1% | 9% |
| AMEAMETEK, Inc. | $56B | 35.9× | 24.1× | 36.6% | 20.0% | 15% |
| AOSA. O. Smith Corporation | $8B | 16.1× | 11.6× | 38.6% | 13.1% | 27% |
| DCIDonaldson Company, Inc. | $10B | 22.1× | 17.9× | 34.6% | 11.7% | 28% |
| DOVDover Corporation | $25B | 22.6× | 15.0× | 39.6% | 13.5% | 15% |
| EMREmerson Electric Co. | $87B | 33.7× | 19.1× | 53.2% | 13.8% | 13% |
| ETNEaton Corporation plc | $170B | 44.5× | 29.6× | 35.9% | 12.8% | 20% |
| FELEFranklin Electric Co., Inc. | $4B | 27.5× | 16.3× | 35.5% | 7.1% | 12% |
| FLSFlowserve Corporation | $10B | 26.8× | 15.7× | 35.1% | 8.0% | 17% |
| GGGGraco Inc. | $13B | 24.3× | 16.7× | 52.6% | 23.5% | 20% |
| IEXIDEX Corporation | $17B | 33.0× | 20.1× | 44.7% | 14.5% | 13% |
| ITTITT Inc. | $19B | 41.4× | 24.8× | 34.6% | 8.9% | 10% |
| ITWIllinois Tool Works Inc. | $79B | 24.7× | 18.9× | 44.2% | 19.4% | 102% |
| XYLXylem Inc. | $25B | 25.9× | 14.6× | 39.2% | 11.1% | 9% |
The median is of the 13 peers listed above and nothing else — check it against the column. This company trades 16.1% above it. The peer set is the vendor’s, so a company can appear here that a person would not have chosen.
What it has traded at
What its sector has traded at
Two scales, drawn separately on purpose: a sector median and one company’s multiple are not the same number and putting them on one axis invites a comparison neither series supports.
Discounted cash flow
| Model | Fair value | Against | Computed |
|---|---|---|---|
| Standard DCF | $71 | $71.75 · −0% | 2026-06-10 |
| Levered DCF | $62 | $71.75 · −14% | 2026-06-10 |
The vendor’s intrinsic-value models. Treat them as a low-growth anchor — for a fast grower the market routinely pays well above a DCF. These were computed against the price in the “against” column, not today’s.
Every estimate on one scale
The vertical rule is the current price. Ranges and point estimates are the backend’s, published as they were calculated; an arrow means the estimate sits beyond this scale, and its number is on the right.